NO984299L - Anvendelse av antiarrytmiske forbindelser for nedsettelse av d°d etter infarkt - Google Patents
Anvendelse av antiarrytmiske forbindelser for nedsettelse av d°d etter infarktInfo
- Publication number
- NO984299L NO984299L NO984299A NO984299A NO984299L NO 984299 L NO984299 L NO 984299L NO 984299 A NO984299 A NO 984299A NO 984299 A NO984299 A NO 984299A NO 984299 L NO984299 L NO 984299L
- Authority
- NO
- Norway
- Prior art keywords
- infarction
- reduce
- antiarrhythmic compounds
- antiarrhythmic
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9603357A FR2746013B1 (fr) | 1996-03-18 | 1996-03-18 | Utilisation de composes antiarythmiques dans la prevention de la mortalite post infarctus |
PCT/FR1997/000474 WO1997034597A1 (fr) | 1996-03-18 | 1997-03-17 | Utilisation de composes antiarythmiques dans la reduction de la mortalite post infarctus |
Publications (2)
Publication Number | Publication Date |
---|---|
NO984299D0 NO984299D0 (no) | 1998-09-17 |
NO984299L true NO984299L (no) | 1998-11-17 |
Family
ID=9490276
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO984299A NO984299L (no) | 1996-03-18 | 1998-09-17 | Anvendelse av antiarrytmiske forbindelser for nedsettelse av d°d etter infarkt |
Country Status (14)
Country | Link |
---|---|
US (1) | US5985915A (xx) |
EP (1) | EP0796617A1 (xx) |
JP (1) | JP3253092B2 (xx) |
KR (1) | KR20000064760A (xx) |
CN (1) | CN1213965A (xx) |
AU (1) | AU719358B2 (xx) |
CA (1) | CA2249481A1 (xx) |
FR (1) | FR2746013B1 (xx) |
HU (1) | HUP9902580A3 (xx) |
IL (1) | IL125980A0 (xx) |
NO (1) | NO984299L (xx) |
NZ (1) | NZ331931A (xx) |
WO (1) | WO1997034597A1 (xx) |
ZA (1) | ZA972340B (xx) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5785995A (en) * | 1997-04-11 | 1998-07-28 | Upsher-Smith Laboratories, Inc. | Pharmaceutical tablet of amiodarone salt |
FR2764800B1 (fr) * | 1997-06-23 | 1999-09-10 | Sanofi Sa | Composition pharmaceutique solide contenant des derives de benzofuranne |
US6583198B2 (en) | 1997-11-28 | 2003-06-24 | Hitachi Chemical Company, Ltd. | Photo curable resin composition and photosensitive element |
DE19820151A1 (de) * | 1998-05-06 | 1999-11-11 | Hexal Ag | Transdermales therapeutisches System zur Anwendung von Candesartan |
WO2000004862A2 (en) * | 1998-07-20 | 2000-02-03 | Smithkline Beecham Corporation | Bioenhanced formulations comprising eprosartan in oral solid dosage form |
CN1195524C (zh) | 1998-09-10 | 2005-04-06 | 阿文蒂斯药物德国有限公司 | 苯磺酰(硫)脲与β-受体阻滞剂联合在制备用于心脏迷走神经机能障碍治疗和预防的药物中的用途 |
AU1157500A (en) * | 1998-11-06 | 2000-05-29 | Boehringer Ingelheim International Gmbh | Medicaments based on combinations of lacidipine and telmisartan or of physiological derivatives thereof |
US7378108B1 (en) | 1999-02-19 | 2008-05-27 | Takeda Pharmaceutical Company Limited | Percutaneous absorption preparation of compound having angiotensin II antagonistic activity |
EA003052B1 (ru) * | 1999-07-27 | 2002-12-26 | Балканфарма Холдинг АД | Антиаритмическое лекарственное средство |
FR2817750B1 (fr) * | 2000-12-11 | 2003-02-21 | Sanofi Synthelabo | Composition pharmaceutique de dronedarone pour administration parenterale |
US7413751B2 (en) * | 2001-10-25 | 2008-08-19 | Depomed, Inc. | Methods of treatment using a gastric retained losartan dosage |
EG24716A (en) * | 2002-05-17 | 2010-06-07 | Novartis Ag | Combination of organic compounds |
JP4694967B2 (ja) * | 2003-07-31 | 2011-06-08 | 久光製薬株式会社 | 貼付剤 |
DE602005025755D1 (de) | 2004-06-04 | 2011-02-17 | Teva Pharma | Irbesartan enthaltende pharmazeutische zusammensetzung |
GB0719180D0 (en) | 2007-10-02 | 2007-11-14 | Cambrex Karlskoga Ab | New process |
CN102065855A (zh) * | 2008-04-17 | 2011-05-18 | 赛诺菲-安万特 | 决奈达隆在制备用于预防因心血管疾病住院或死亡的药物中的用途 |
FR2930148A1 (fr) * | 2008-04-17 | 2009-10-23 | Sanofi Aventis Sa | Utilisation de la dronedarone pour la preparation d'un medicament destine a la prevention de l'hospitalisation cardiovasculaire ou de la mortalite |
FR2930149B1 (fr) * | 2008-04-17 | 2011-02-18 | Sanofi Aventis | Association de dronedarone avec au moins un diuretique, son application en therapeutique |
EP2116239A1 (en) * | 2008-04-29 | 2009-11-11 | Sanofi-Aventis | Method for managing the risks associated with an increase in serum creatinine during dronedarone treatment |
WO2011135581A2 (en) * | 2010-04-28 | 2011-11-03 | Cadila Healthcare Limited | Pharmaceutical compositions of dronedarone |
US8602215B2 (en) | 2010-06-30 | 2013-12-10 | Sanofi | Methods for reducing the risk of an adverse dronedarone/beta-blockers interaction in a patient suffering from atrial fibrillation |
EP2431033A1 (en) | 2010-08-10 | 2012-03-21 | Sanofi | Dronedarone for preventing cardiovascular hospitalization or mortality in patients with lone atrial fibrillation |
WO2012020377A1 (en) | 2010-08-11 | 2012-02-16 | Sanofi | Use of dronedarone for the preparation of a medicament for rhythm- and rate-controlling in patients with atrial fibrillation |
US20130116586A1 (en) | 2011-07-07 | 2013-05-09 | Sanofi | Use of dronedarone or a pharmaceutically acceptable salt thereof for the preparation of a drug for the prevention of atrial fibrillation |
WO2013024411A1 (en) | 2011-08-12 | 2013-02-21 | Lupin Limited | Co-milled formulation of dronedarone |
CN102526469B (zh) * | 2012-02-16 | 2013-07-10 | 罗群 | 一种用于心梗后康复的复方药物及其制备方法 |
EP2674158B9 (en) * | 2012-06-14 | 2015-11-18 | Szegedi Tudományegyetem | Treatment and prevention of cardiac arrhythmias |
CN104414970A (zh) * | 2013-09-10 | 2015-03-18 | 成都力思特制药股份有限公司 | 一种盐酸胺碘酮注射液及其制备方法 |
WO2018002673A1 (en) | 2016-07-01 | 2018-01-04 | N4 Pharma Uk Limited | Novel formulations of angiotensin ii receptor antagonists |
CN107753439A (zh) * | 2016-08-22 | 2018-03-06 | 黑龙江迪龙制药有限公司 | 一种注射用盐酸胺碘酮及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2550091B1 (fr) * | 1983-08-02 | 1986-05-23 | Sanofi Sa | Composition pharmaceutique ou veterinaire destinee a combattre des troubles ischemiques cardiaques contenant un derive du benzofuranne |
US5252600A (en) * | 1988-01-25 | 1993-10-12 | Soorianarain Baligadoo | Synergistic compositions for the treatment of coronary insufficiency and methods of use thereof |
FR2626176A1 (fr) * | 1988-01-25 | 1989-07-28 | Baligadoo Soorianarain | Preparations medicamenteuses cardioprotectrices comprenant l'amiodarone un derive nitre, et facultativement un beta-bloqueur |
FR2665444B1 (fr) * | 1990-08-06 | 1992-11-27 | Sanofi Sa | Derives d'amino-benzofuranne, benzothiophene ou indole, leur procede de preparation ainsi que les compositions les contenant. |
AU7854094A (en) * | 1993-10-04 | 1995-05-01 | Handforth Investments Ltd. | Use of amiodarone for the treatment of heart failure |
-
1996
- 1996-03-18 FR FR9603357A patent/FR2746013B1/fr not_active Expired - Fee Related
-
1997
- 1997-03-17 US US08/819,863 patent/US5985915A/en not_active Expired - Fee Related
- 1997-03-17 WO PCT/FR1997/000474 patent/WO1997034597A1/fr not_active Application Discontinuation
- 1997-03-17 EP EP97400593A patent/EP0796617A1/fr not_active Withdrawn
- 1997-03-17 JP JP53320197A patent/JP3253092B2/ja not_active Expired - Fee Related
- 1997-03-17 KR KR1019980707523A patent/KR20000064760A/ko active IP Right Grant
- 1997-03-17 CA CA002249481A patent/CA2249481A1/fr not_active Abandoned
- 1997-03-17 HU HU9902580A patent/HUP9902580A3/hu unknown
- 1997-03-17 CN CN97193158A patent/CN1213965A/zh active Pending
- 1997-03-17 NZ NZ331931A patent/NZ331931A/xx unknown
- 1997-03-17 IL IL12598097A patent/IL125980A0/xx unknown
- 1997-03-17 AU AU22962/97A patent/AU719358B2/en not_active Ceased
- 1997-03-18 ZA ZA972340A patent/ZA972340B/xx unknown
-
1998
- 1998-09-17 NO NO984299A patent/NO984299L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO984299D0 (no) | 1998-09-17 |
IL125980A0 (en) | 1999-04-11 |
NZ331931A (en) | 2000-08-25 |
FR2746013B1 (fr) | 1998-05-29 |
AU719358B2 (en) | 2000-05-04 |
AU2296297A (en) | 1997-10-10 |
CN1213965A (zh) | 1999-04-14 |
JP3253092B2 (ja) | 2002-02-04 |
FR2746013A1 (fr) | 1997-09-19 |
ZA972340B (en) | 1998-09-18 |
US5985915A (en) | 1999-11-16 |
KR20000064760A (ko) | 2000-11-06 |
CA2249481A1 (fr) | 1997-09-25 |
JPH11507063A (ja) | 1999-06-22 |
WO1997034597A1 (fr) | 1997-09-25 |
HUP9902580A3 (en) | 2001-08-28 |
EP0796617A1 (fr) | 1997-09-24 |
HUP9902580A2 (hu) | 2001-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO984299L (no) | Anvendelse av antiarrytmiske forbindelser for nedsettelse av d°d etter infarkt | |
EE9900259A (et) | Ühendi uus vorm | |
HU9702036D0 (en) | New heterocyclic compounds as inhibitors of leucocita-adhesion and wla-4-antagonists | |
PL333918A1 (en) | Derivatives of 6-phenylpyryidil-2-amine useful as nos inhibitors | |
DE69704183D1 (de) | Bohrlochzementzusammensetzung | |
EP1005343A4 (en) | USE OF CSAIDS AS ANGIOGENESIS INHIBITORS | |
NO984290D0 (no) | Farmas°ytisk nyttige forbindelser | |
DK0788496T3 (da) | Inhibitorer for syntese af apolipoprotein-B | |
DK0839806T3 (da) | Substituerede tricykliske forbindelser | |
EE9800430A (et) | Uued ühendid | |
DE69700310D1 (de) | Rostschutzzusammensetzung | |
ID18446A (id) | Proses untuk isomerisasi hidrokarbon-hidrokarbon alkilaromatik | |
ID17561A (id) | Komposisi untuk pemakaian luar | |
ID22060A (id) | Senyawa-senyawa 2-imidazolinilaminobenzoksazol berguna sebagai agonis adrenoseptor | |
ID19679A (id) | Senyawa furan nitron | |
NO990832D0 (no) | Syntese av bisendolylmalimider | |
ID16838A (id) | Komposisi dekafluoropentana | |
ID16998A (id) | Komposisi batang sabun | |
AU4945697A (en) | Solid phase synthesis of heterocyclic compounds | |
ID17424A (id) | Penghambat matriks metaloproteasa oleh senyawa-senyawa fenetil tersubstitusi | |
NO983479D0 (no) | Sementsammensetning | |
IS4932A (is) | Ný efnasambönd | |
ID17419A (id) | Komposisi dekafluoropentana | |
FI991343A (fi) | Dihydropolyprenolien öljykoostumus | |
DE69733921D1 (de) | Stämme der Biefhefe |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |